H1N1 Influenza (Human Swine Flu) Outbreak

H1N1 INFLUENZA 09 (HUMAN SWINE INFLUENZA) OUTBREAK
Members seeking information regarding the H1N1 Influenza Outbreak are recommended to check the Department of Health and Ageing (DOHA) website and their local Department of Health website for updated information. The following links are provided for assistance: Department of Health and Ageing (DOHA) DOHA H1N1 Influenza Outbreak website H1N1 Influenza Fact Sheel (DOHA) Useful information for health professionals Update Bulletins Jurisdictional links: For specific information regarding your state or territory please check the following links – should Branches have any additional Health Department links they would like included please advise SHPA. ACT - http://www.health.act.gov.au/c/health?a=&did=11044035 NSW - http://www.emergency.health.nsw.gov.au/swineflu/index.asp NT - http://www.health.nt.gov.au/Centre_for_Disease_Control/index.aspx Qld - http://www.health.qld.gov.au/swineflu/ SA - http://www.flu.sa.gov.au/Swineflu.aspx Tas - http://www.pandemic.tas.gov.au/ Vic - http://health.vic.gov.au/ideas/diseases/swine-influenza http://humanswineflu.health.vic.gov.au/practitioners/index.htm WA - http://www.health.wa.gov.au/swine_flu/home/ Oseltamivir (Tamiflu) Roche Products Australia Roche Products Australia is working with the Federal Government and other stakeholders including relevant health authorities in the provision of antiviral medication as required. The Roche website shows all available accurate and up to date information about Swine Influenza and the supply and access to Tamiflu (oseltamivir). Tamiflu dosing administration update for hospitals - 5 June 2009 August update - unavailability of Tamiflu (oseltamivir) suspension - 14 August 2009 Paediatric Dosing There have been several questions regarding use of oseltamivir (Tamiflu) in infants less than 12 months of age. It is noted that the current TGA product approval and information of oseltamivir is for children greater than 1 year of age. Information on this issue can be read in an opinion from the European Medicines Agency website at: http://www.emea.europa.eu/humandocs/PDFs/EPAR/tamiflu/27883809en.pdf. Alternatively enquiries could be directed to major paediatric hospitals in your jurisdiction (for example in Victoria at the Royal Children’s Hospital information can be found at http://www.rch.org.au/clinicalguide/cpg.cfm?doc_id=12820) . It should be noted that the current oseltamivir (Tamiflu) suspension provides an oral syringe which is calibrated in 30, 45, 60 and 75 mg dosages, should smaller doses be required a normal 3 or 5 mL syringe should be provided. H1N1 Vaccine (Panvax) Go to this page on the Australian Prescriber website for independent information about the recently released H1N1 vaccine from CSL.

H1N1 INFLUENZA 09 (HUMAN SWINE INFLUENZA) OUTBREAK

Members seeking information regarding the H1N1 Influenza Outbreak are recommended to check the Department of Health and Ageing (DOHA) website and their local Department of Health website for updated information. The following links are provided for assistance:

Department of Health and Ageing (DOHA)

Jurisdictional links:

For specific information regarding your state or territory please check the following links – should Branches have any additional Health Department links they would like included please advise SHPA.

ACT - http://www.health.act.gov.au/c/health?a=&did=11044035

NSW - http://www.emergency.health.nsw.gov.au/swineflu/index.asp

NT - http://www.health.nt.gov.au/Centre_for_Disease_Control/index.aspx

Qld - http://www.health.qld.gov.au/swineflu/

SA - http://www.flu.sa.gov.au/Swineflu.aspx

Tas - http://www.pandemic.tas.gov.au/

Vic - http://health.vic.gov.au/ideas/diseases/swine-influenza
http://humanswineflu.health.vic.gov.au/practitioners/index.htm

WA - http://www.health.wa.gov.au/swine_flu/home/

Oseltamivir (Tamiflu)

Roche Products Australia
Roche Products Australia is working with the Federal Government and other stakeholders including relevant health authorities in the provision of antiviral medication as required. The Roche website shows all available accurate and up to date information about Swine Influenza and the supply and access to Tamiflu (oseltamivir).
Tamiflu dosing administration update for hospitals - 5 June 2009
August update - unavailability of Tamiflu (oseltamivir) suspension - 14 August 2009

Paediatric Dosing
There have been several questions regarding use of oseltamivir (Tamiflu) in infants less than 12 months of age. It is noted that the current TGA product approval and information of oseltamivir is for children greater than 1 year of age. Information on this issue can be read in an opinion from the European Medicines Agency website at: http://www.emea.europa.eu/humandocs/PDFs/EPAR/tamiflu/27883809en.pdf. Alternatively enquiries could be directed to major paediatric hospitals in your jurisdiction (for example in Victoria at the Royal Children’s Hospital information can be found at http://www.rch.org.au/clinicalguide/cpg.cfm?doc_id=12820) . It should be noted that the current oseltamivir (Tamiflu) suspension provides an oral syringe which is calibrated in 30, 45, 60 and 75 mg dosages, should smaller doses be required a normal 3 or 5 mL syringe should be provided.